There was also no clear evidence of a significant trend in the number of hospital presentations involving exposure to non‐SCRA drugs before or after either of these two policy changes.
← all excerpts
Trends in hospital presentations following analytically confirmed synthetic cannabinoid receptor agonist exposure before and after implementation of the 2016 UK Psychoactive Substances Act.
1
—
—